Thirty Technology joins the fight against antibiotic resistant infection.
30 Technology enters into a strategic Licencing Agreement to develop new treatments for multi-drug resistant tuberculosis
read more
Thirty Technology joins the fight against antibiotic resistant infection.
RESP301 to combat antibiotic resistant/refractory infection in people with cystic fibrosis